MedPath

Semmelweis University

Semmelweis University logo
🇭🇺Hungary
Ownership
Private, Subsidiary
Established
1769-01-01
Employees
1
Market Cap
-
Website
http://www.sote.hu

Clinical Trials

121

Active:16
Completed:55

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:3
Phase 2:4
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (86 trials with phase data)• Click on a phase to view related trials

Not Applicable
59 (68.6%)
Phase 4
13 (15.1%)
Phase 3
5 (5.8%)
Phase 2
4 (4.7%)
Phase 1
3 (3.5%)
Early Phase 1
2 (2.3%)

Healing of Intrabony Defects Following Treatment With PRF or EMD

Not Applicable
Completed
Conditions
Periodontal Bone Loss
Periodontal Disease
Platelet Rich Fibrin
First Posted Date
2025-09-19
Last Posted Date
2025-09-19
Lead Sponsor
Semmelweis University
Target Recruit Count
28
Registration Number
NCT07183631
Locations
🇭🇺

Semmelweis University, Budapest, Hungary

Adaptation of Pediatric Speech Audiometry Tests Into Other Languages

Recruiting
Conditions
Hearing Loss
Screening
First Posted Date
2025-09-05
Last Posted Date
2025-09-05
Lead Sponsor
Semmelweis University
Target Recruit Count
120
Registration Number
NCT07156825
Locations
🇭🇺

Semmelweis University, Budapest, Hungary

Shoulder Injury Prevention in Adolescent Handball Players Based on Scandinavian Protocols

Not Applicable
Active, not recruiting
Conditions
Injury Prevention
Shoulder Injuries
First Posted Date
2025-08-28
Last Posted Date
2025-09-08
Lead Sponsor
Semmelweis University
Target Recruit Count
137
Registration Number
NCT07146243
Locations
🇭🇺

FTC Handball Academy, Budapest, Hungary

Speech of Kids After Neonatal Encephalopathy

Recruiting
Conditions
HIE - Hypoxic - Ischemic Encephalopathy
Language Delay
Autism
ADHD - Attention Deficit Disorder With Hyperactivity
Specific Language Impairment
Intellectual Developmental Disorder
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
Semmelweis University
Target Recruit Count
93
Registration Number
NCT07136636
Locations
🇭🇺

Semmelweis University, Budapest, Hungary

Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws

Not Applicable
Not yet recruiting
Conditions
Edentulous Alveolar Ridge
Edentulous Alveolar Ridge Atrophy
First Posted Date
2025-08-05
Last Posted Date
2025-09-04
Lead Sponsor
Semmelweis University
Target Recruit Count
30
Registration Number
NCT07104370
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

News

Algernon NeuroScience Launches Phase 2a Trial of DMT for Stroke Recovery with Leading Neurologist

Algernon NeuroScience appoints Dr. Sándor Nardai to lead a groundbreaking Phase 2a clinical trial investigating DMT as a potential stroke recovery treatment, set to begin in Q3 2025.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.